PALM

ZimVie Announces Closing of Sale of Spine Business

Retrieved on: 
Monday, April 1, 2024

PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G.

Key Points: 
  • PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G.
  • Capital for $375 million in total consideration, including $315 million in cash and a $60 million promissory note.
  • “The completion of the sale of our Spine business is the culmination of months of partnership with H.I.G.
  • Capital and years of commitment from our global Spine team members; I would like to thank everyone for their immense contributions,” said Vafa Jamali, President and Chief Executive Officer.

McWhorter Foundation To Sue Nelson Peltz & Trian Partners For Market Manipulation: C.K. McWhorter Protecting Millennial & Gen Z Shareholder Interests and Exposing Short-Term Tactics

Retrieved on: 
Friday, March 29, 2024

Recent developments have raised alarms about strategies that prioritize immediate returns over sustainable growth and economic health.

Key Points: 
  • Recent developments have raised alarms about strategies that prioritize immediate returns over sustainable growth and economic health.
  • The foundation highlights the inherent risks of market manipulation, including misleading information dissemination and other deceptive practices that can harm uninformed investors and destabilize the market.
  • The Economic Toll on Gen Z, Millennials, and Retail Investors
    The McWhorter Foundation emphasizes the disproportionate impact these strategies have on younger generations, including Gen Z and Millennials.
  • The McWhorter Foundation reaffirms its dedication to promoting practices that ensure sustainable growth, economic integrity, and the protection of shareholder value against predatory behaviors.

C.K. McWhorter Slams Nelson Peltz For Attempting To Ruin Disney's Luxury Essence and Visionary Future

Retrieved on: 
Friday, March 29, 2024

"At 81 years old, Nelson Peltz's understanding of luxury seems frozen in time, much like the era in which he was born," McWhorter declares.

Key Points: 
  • "At 81 years old, Nelson Peltz's understanding of luxury seems frozen in time, much like the era in which he was born," McWhorter declares.
  • "His failure to grasp the true essence of Disney as a luxury brand underscores his limited exposure to diverse perspectives and his residence within the protective bubble of privilege."
  • In a scathing indictment of Peltz's remarks, McWhorter dismantles the notion that Disney's inclusive storytelling is incompatible with luxury, asserting that diversity and representation are integral components of Disney's allure.
  • As Disney embarks on a journey toward the future, McWhorter calls for leadership that understands the true essence of luxury and embraces the values of diversity, creativity, and innovation.

McWhorter Foundation Combats Nelson Peltz’s Outdated Ideologies and Advocates for Sustainable Inclusivity In Corporate Leadership

Retrieved on: 
Friday, March 29, 2024

McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction.

Key Points: 
  • McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction.
  • While briefly meeting Nelson Peltz and shaking hands after both departed separate lunches, McWhorter initially respected his insights.
  • However, recent comments made by Peltz suggesting Disney should avoid inclusive films have raised eyebrows and prompted McWhorter to speak out.
  • McWhorter Foundation has not registered with the U.S. Securities and Exchange Commission (SEC) and may operate under exemptions.

McWhorter Foundation Preparing Legal Battle Against J.P. Morgan Over IPO Discrimination and LBO Biases

Retrieved on: 
Thursday, March 28, 2024

PALM BEACH, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- McWhorter Foundation is poised to launch a groundbreaking legal battle against financial giant J.P. Morgan.

Key Points: 
  • PALM BEACH, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- McWhorter Foundation is poised to launch a groundbreaking legal battle against financial giant J.P. Morgan.
  • McWhorter's legal challenge will illuminate these inequities, compelling J.P. Morgan to address its role in perpetuating barriers to entry for underrepresented entrepreneurs.
  • Backed by comprehensive data and extensive research, McWhorter's legal team will present compelling evidence of discrimination in J.P. Morgan's IPO practices.
  • As preparations for legal action intensify, the McWhorter Foundation calls upon individuals and organizations to join the movement for economic justice.

QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss

Retrieved on: 
Thursday, March 28, 2024

Moreover, the Company significantly reduced its net operating loss, underscoring its enhanced operational efficiency and fiscal stewardship.

Key Points: 
  • Moreover, the Company significantly reduced its net operating loss, underscoring its enhanced operational efficiency and fiscal stewardship.
  • Revenue Growth: QHSLab achieved revenues of $1,408,995 in 2023, a notable increase from $1,243,186 in 2022.
  • Gross Profit and Margin Improvement: The company generated a gross profit of $793,607 with a gross margin increase to 56.3% in 2023 from 49.8% in 2022.
  • Reduced Net Operating Loss: QHSLab markedly reduced its net operating loss to $(240,158) in 2023 from $(560,539) in 2022, highlighting the Company’s overall improvement in operating efficiency and financial management.

Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth

Retrieved on: 
Wednesday, March 27, 2024

In diagnostics, AI enables healthcare providers to make the most appropriate treatment decisions for their patients.

Key Points: 
  • In diagnostics, AI enables healthcare providers to make the most appropriate treatment decisions for their patients.
  • Mordor Intelligence continued: “The increased prevalence of cancer and the high burden of other chronic diseases are, in turn, increasing the demand for accurate diagnosis and treatment.
  • This is likely to increase the adoption of AI for early diagnosis purposes, ultimately boosting the market growth.
  • The use of artificial intelligence in the North American healthcare market is being driven by the increasing use of advanced technology in healthcare systems, the growth in funding of AI-based startups, the rising burden of chronic diseases in the country, the growing need to reduce healthcare costs, and the implementation of big data in healthcare.

HR Community Readies for Next Month’s EPIC Conference in Las Vegas

Retrieved on: 
Wednesday, March 27, 2024

WEST PALM BEACH, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- In only a few short weeks, the HR community will come together for the inaugural Elevate People, Ignite Change (EPIC) Conference taking place at the Bellagio in Las Vegas, April 24 – 26, 2024.

Key Points: 
  • WEST PALM BEACH, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- In only a few short weeks, the HR community will come together for the inaugural Elevate People, Ignite Change (EPIC) Conference taking place at the Bellagio in Las Vegas, April 24 – 26, 2024.
  • “Fostering Gen Z Engagement: Balancing Identity, Advocacy and HR for Business Success” – Set to comprise 30 percent of the workforce by 2030, Gen Z is the most disengaged generation at work today.
  • In a world redefined by generational shifts, technological advancement, social change and the rising cost of living, EPIC bravely confronts the challenges that employees and HR leaders alike are facing head-on.
  • To be part of this EPIC event, register now by visiting https://www.epichr.com/register .

C.K. McWhorter Opens Conversations With Goldman Sachs A Historic Odyssey In Finance

Retrieved on: 
Tuesday, March 26, 2024

McWhorter, a visionary entrepreneur and advocate for ESG (Environmental, Social, and Governance) initiatives, announces the commencement of discussions with Goldman Sachs, a leading global investment bank.

Key Points: 
  • McWhorter, a visionary entrepreneur and advocate for ESG (Environmental, Social, and Governance) initiatives, announces the commencement of discussions with Goldman Sachs, a leading global investment bank.
  • The talks with Goldman Sachs symbolize the convergence of strategic vision, financial expertise, and a resolute commitment to advancing ESG principles in high finance.
  • The Role of Goldman Sachs:
    In initiating discussions with Goldman Sachs, McWhorter seeks a strategic partner that shares his values and can provide unparalleled expertise in navigating complex financial landscapes.
  • As discussions with Goldman Sachs unfold, McWhorter remains steadfast in his mission to revolutionize the finance industry and create lasting positive change.

RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES

Retrieved on: 
Tuesday, March 26, 2024

WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on March 21, 2024, and that on March 20, 2024, the Company and certain institutional warrant holders agreed that, with regard to Series B Warrants to acquire 101,350,000,000 shares of common stock, subject to certain terms, the termination date of such Warrants would be extended from March 21, 2024 to December 31, 2025.

Key Points: 
  • WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on March 21, 2024, and that on March 20, 2024, the Company and certain institutional warrant holders agreed that, with regard to Series B Warrants to acquire 101,350,000,000 shares of common stock, subject to certain terms, the termination date of such Warrants would be extended from March 21, 2024 to December 31, 2025.
  • “The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”